Eli Lilly returns to Indianapolis the week of a $4.5 billion manufacturing expansion

Eli Lilly flew from Westchester County Airport to Indianapolis International Airport on May 19, 2026, a 1-hour-38-minute hop in Gulfstream G500 N308EL. The flight arrived at 12:11 p.m. local time, returning the company's executives to headquarters after a day trip to the New York area.

The same week, Eli Lilly announced an additional $4.5 billion investment across two of its Lebanon, Indiana, manufacturing sites, per a May 6 press release on [prnewswire.com](https://www.prnewswire.com/news-releases/302763332.html). The commitment brings the company's total Indiana capital expansion since 2020 to more than $21 billion. The Lebanon campus opened its first dedicated genetic medicine facility on May 6, and the company plans to begin production of Foundayo (orforglipron), its newly approved oral weight-loss pill, at the site when it opens in 2027.

The Indianapolis-based pharmaceutical giant has been shuttling frequently between its home base and the Northeast corridor in recent weeks. N308EL flew from Indianapolis to Westchester on May 18, and to Boston on May 11, and back to Indianapolis on May 12 — a pattern consistent with investor meetings and regulatory work as Eli Lilly rolls out Foundayo, which has already reached more than 20,000 patients, per [indystar.com](https://www.indystar.com/story/news/health/2026/04/30/more-than-20k-people-on-oral-glp-1-pill-as-eli-lilly-ramps-up-access/89859338007/).